CHRS
Coherus Oncology, Inc. · Healthcare
Director Mats Wahlstrom sold $213K of Coherus Oncology, Inc.
Sold$213,475
$33.50Price
6,372Shares
−1%Stake
What CHRS did after the filing
Prices for CHRS after this filing aren't in yet.
Traded Tue, Aug 18. Filed Thu, May 26. Not investment advice.